Latest Insider Transactions at Arcutis Biotherapeutics, Inc. (ARQT)
This section provides a real-time view of insider transactions for Arcutis Biotherapeutics, Inc. (ARQT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Arcutis Biotherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Arcutis Biotherapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2021
|
Patrick Burnett Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,750
+38.95%
|
-
|
|
Dec 27
2021
|
Scott L Burrows Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,560
-35.64%
|
$251,200
$20.07 P/Share
|
|
Dec 23
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,500
-1.36%
|
$50,000
$20.16 P/Share
|
|
Dec 23
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+1.34%
|
$0
$0.58 P/Share
|
|
Dec 08
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.17%
|
$17,000
$17.0 P/Share
|
|
Dec 08
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.17%
|
$1,000
$1.68 P/Share
|
|
Nov 05
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.17%
|
$21,000
$21.5 P/Share
|
|
Nov 05
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.17%
|
$1,000
$1.68 P/Share
|
|
Nov 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,500
-1.36%
|
$52,500
$21.81 P/Share
|
|
Nov 01
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+1.34%
|
$0
$0.58 P/Share
|
|
Oct 05
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
2,500
-0.42%
|
$60,000
$24.92 P/Share
|
|
Oct 05
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+0.42%
|
$2,500
$1.68 P/Share
|
|
Oct 01
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,500
-0.25%
|
$37,500
$25.01 P/Share
|
|
Oct 01
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+0.25%
|
$1,500
$1.68 P/Share
|
|
Oct 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,500
-1.36%
|
$57,500
$23.87 P/Share
|
|
Oct 01
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+1.34%
|
$0
$0.58 P/Share
|
|
Sep 07
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.17%
|
$21,000
$21.14 P/Share
|
|
Sep 07
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.17%
|
$1,000
$1.68 P/Share
|
|
Sep 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
5,000
-1.34%
|
$100,000
$20.99 P/Share
|
|
Sep 01
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.31%
|
$5,000
$1.13 P/Share
|
|
Aug 05
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,000
-0.17%
|
$20,000
$20.81 P/Share
|
|
Aug 05
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.17%
|
$1,000
$1.68 P/Share
|
|
Jul 06
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,750
-0.29%
|
$45,500
$26.58 P/Share
|
|
Jul 06
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+0.29%
|
$1,750
$1.68 P/Share
|
|
Jul 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,200
-0.6%
|
$57,200
$26.45 P/Share
|
|
Jul 01
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+0.4%
|
$6,600
$3.29 P/Share
|
|
Jun 25
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
6,755
-0.8%
|
$182,385
$27.5 P/Share
|
|
Jun 24
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
729
-0.09%
|
$19,683
$27.5 P/Share
|
|
Jun 21
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
2,516
-0.3%
|
$67,932
$27.5 P/Share
|
|
Jun 18
2021
|
Todd Franklin Watanabe Director |
BUY
Other acquisition or disposition
|
Indirect |
7,377
+11.4%
|
-
|
|
Jun 07
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,750
-0.29%
|
$45,500
$26.35 P/Share
|
|
Jun 07
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+0.29%
|
$1,750
$1.68 P/Share
|
|
Jun 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,200
-0.51%
|
$59,400
$27.34 P/Share
|
|
Jun 01
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+0.34%
|
$6,600
$3.29 P/Share
|
|
Jun 01
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
10,000
-1.16%
|
$270,000
$27.5 P/Share
|
|
May 21
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,612
+0.38%
|
$1,612
$1.13 P/Share
|
|
May 10
2021
|
Frazier Life Sciences Viii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
96,574
-100.0%
|
-
|
|
May 10
2021
|
Frazier Life Sciences Viii, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
96,574
+50.0%
|
-
|
|
May 10
2021
|
Frazier Life Sciences Viii, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
2,108,558
-20.0%
|
-
|
|
May 07
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
750
-0.13%
|
$26,250
$35.0 P/Share
|
|
May 07
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+0.13%
|
$750
$1.68 P/Share
|
|
May 05
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,750
-0.29%
|
$59,500
$34.0 P/Share
|
|
May 05
2021
|
Todd Franklin Watanabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,607
+0.27%
|
$1,607
$1.68 P/Share
|
|
May 03
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,200
-0.52%
|
$74,800
$34.84 P/Share
|
|
May 03
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+0.34%
|
$6,600
$3.29 P/Share
|
|
Apr 30
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,500
-0.25%
|
$52,500
$35.0 P/Share
|
|
Apr 20
2021
|
Bhaskar Chaudhuri Director |
SELL
Open market or private sale
|
Direct |
10,000
-0.57%
|
$280,000
$28.26 P/Share
|
|
Apr 16
2021
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,655
+0.42%
|
$2,655
$1.31 P/Share
|
|
Apr 05
2021
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
1,750
-0.29%
|
$50,750
$29.93 P/Share
|
|
Apr 01
2021
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
2,200
-0.52%
|
$63,800
$29.5 P/Share
|